You are correct. This offering if executed today would imo be almost criminal as they still have plenty of cash for another year and the recovery of the main market is likely in short term as the virus panic eventually dies down...and it will. If the company can wait until summer or fall before doing this offering I think we will be in a much better position to keep dilution to a minimum.
I would much rather see an offering at a fixed price rather than this drip, drip drip form of financing. At least with a fixed price you’d know where support/resistance lies regarding the financing...
My opinion pertains to any company and based on forty years experience in the markets. It doesn’t mean I’m always right but it’s worked for me all these years to avoid major losses, especially in biotech...
News 
Market Data 
Discover 
